Current Prostate Reports

, Volume 2, Issue 4, pp 171–178 | Cite as

Holmium laser enucleation of the prostate: Methods and outcomes

  • Samuel C. Kim
  • James E. Lingeman
Article
First Online:
  • 11 Downloads

Abstract

Minimally invasive treatments maximize surgical therapy while minimizing patient morbidity. The treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia recently has seen a large growth of minimally invasive technologies. The Holmium laser has become a mainstay for the treatment of urolithiasis and the Holmium’s versatility allows for the treatment of prostatic enlargement regardless of size. The Holmium laser has excellent cutting and coagulating capabilities and allows for a bloodless procedure. Holmium laser enucleation of the prostate, because of its excellent hemostasis and unparalleled ability to endoscopically remove prostatic tissue, has become the treatment of choice for benign prostatic hyperplasia at the Methodist Hospital of Indiana.

Keywords

Benign Prostatic Hyperplasia Lower Urinary Tract Symptom Bladder Neck American Urologic Association Holmium Laser 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kirby RS: The natural history of benign prostatic hyperplasia: What have we learned in the last decade? Urology 2000, 56(suppl 1):3–6.PubMedCrossRefGoogle Scholar
  2. 2.
    McNeal JE: Origin and evolution of benign prostatic enlargement. Invest Urol 1978, 15:340–345.PubMedGoogle Scholar
  3. 3.
    AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia. J Urol 2003, 170:530–547. Current AUA guidelines on the diagnosis and management of BPH.CrossRefGoogle Scholar
  4. 4.
    Lepor H: Medical therapy for benign prostatic hyperplasia. Urology 1993, 42:483–501.PubMedCrossRefGoogle Scholar
  5. 5.
    Lepor H: Natural history, evaluation, and nonsurgical management of benign prostatic hyperplasia. In Campbell’s Urology, edn 8. Edited by Walsh PC, Retik ED, Vaughn ED, Wein AJ. Philadelphia: WB Saunders; 1998:1453–1477.Google Scholar
  6. 6.
    Kirby RS, Roehrborn C, Boyle P, et al.: Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in the treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. Urology 2003, 61:119–126.PubMedCrossRefGoogle Scholar
  7. 7.
    Lepor H, Williford WO, Barry MJ, et al.: The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response: Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. J Urol 1998, 160:1358–1367.PubMedCrossRefGoogle Scholar
  8. 8.
    Lepor H, Williford WO, Barry MJ, et al.: The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia: Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996, 335:533–539.PubMedCrossRefGoogle Scholar
  9. 9.
    McConnell JD, Roehrborn CG, Bautista OM, et al.: The longterm effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003, 349:2387–2398.PubMedCrossRefGoogle Scholar
  10. 10.
    Mebust WK, Holtgrewe HL, Cockett AT, et al.: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989, 141:243–247.PubMedGoogle Scholar
  11. 11.
    Moody JA, Lingeman JE: Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol 2001, 165:459–462.PubMedCrossRefGoogle Scholar
  12. 12.
    Kuntz RM, Lehrich K: Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm: a randomized prospective trial of 120 patients. J Urol 2002, 168:1465–1469. Large randomized, prospective trial of HoLEP versus open prostatectomy.PubMedCrossRefGoogle Scholar
  13. 13.
    Kuntz RM, Lehrich K, Ahyai S: Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol 2004, 18:189–191.PubMedCrossRefGoogle Scholar
  14. 14.
    Nishioka NS, Domankevitz Y, Flotte TJ, et al.: Ablation of rabbit liver, stomach, and colon with a pulsed holmium laser. Gastroenterology 1989, 96:831–837.PubMedGoogle Scholar
  15. 15.
    Johnson DE, Cromeens DM, Price RE: Use of the holmium:YAG laser in urology. Lasers Surg Med 1992, 12:353–363.PubMedCrossRefGoogle Scholar
  16. 16.
    Kuo RL, Kim SC, Lingeman JE, et al.: Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75-gram enucleations. J Urol 2003, 170:149–152.PubMedCrossRefGoogle Scholar
  17. 17.
    Kabalin JN: Holmium:YAG laser prostatectomy: results of U.S. pilot study. J Endourol 1996, 10:453–457.PubMedCrossRefGoogle Scholar
  18. 18.
    Mottet N, Anidjar M, Bourdon O, et al.: Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999, 13:127–130.PubMedCrossRefGoogle Scholar
  19. 19.
    Gilling PJ, Cass CB, Cresswell MD, et al.: Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996, 47:48–51.PubMedCrossRefGoogle Scholar
  20. 20.
    Gilling PJ, Kennett KM, Fraundorfer MR: Holmium laser enucleation of the prostate for glands larger than 100 g: an endourologic alternative to open prostatectomy. J Endourol 2000, 14:529–531.PubMedCrossRefGoogle Scholar
  21. 21.
    Gilling PJ, Mackey M, Cresswell M, et al.: Holmium laser versus transurethral resection of the prostate: a randomized, prospective trial with 1-year follow-up. J Urol 1999, 162:1640–1644. Prospective, randomized control trial of HoLEP versus TURP. prostatectomy.PubMedCrossRefGoogle Scholar
  22. 22.
    Fraundorfer MR, Gilling PJ: Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998, 33:69–72.PubMedCrossRefGoogle Scholar
  23. 23.
    Kuo RL, Paterson RF, Kim SC, et al.: Holmium laser enucleation of the prostate (HoLEP): a technical update. World J Surg Oncol 2003, 1:6. Good review of the technique of HoLEP.PubMedCrossRefGoogle Scholar
  24. 24.
    Kuntz RM, Lehrich K, Ahyai S: Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol 2004, 18:183–188.PubMedCrossRefGoogle Scholar
  25. 25.
    Tan AH, Gilling PJ, Kennett KM, et al.: A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003, 170:1270–1274.PubMedCrossRefGoogle Scholar
  26. 26.
    Razvi HA, Chun SS, Denstedt JD, Sales JL: Soft-tissue applications of the holmium:YAG laser in urology. J Endourol 1995, 9:387–390.PubMedCrossRefGoogle Scholar
  27. 27.
    Wollin TA, Denstedt JD: The holmium laser in urology. J Clin Laser Med Surg 1998, 16:13–20.PubMedGoogle Scholar
  28. 28.
    Grasso M: Experience with the holmium laser as an endoscopic lithotrite. Urology 1996, 48:199–206.PubMedCrossRefGoogle Scholar
  29. 29.
    Keeley FX Jr, Bibbo M, Bagley DH: Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 1997, 157:1560–1565.PubMedCrossRefGoogle Scholar
  30. 30.
    Watterson JD, Sofer M, Wollin TA, et al.: Holmium: YAG laser endoureterotomy for ureterointestinal strictures. J Urol 2002, 167:1692–1695.PubMedCrossRefGoogle Scholar
  31. 31.
    Singal RK, Denstedt JD, Razvi HA, et al.: Holmium:YAG laser endoureterotomy for treatment of ureteral stricture. Urology 1997, 50:875–880.PubMedCrossRefGoogle Scholar
  32. 32.
    Erhard MJ, Bagley DH: Urologic applications of the holmium laser: preliminary experience. J Endourol 1995, 9:383–386.PubMedCrossRefGoogle Scholar
  33. 33.
    Gilling PJ, Cass CB, Cresswell MD, et al.: The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 1996, 10:459–461.PubMedCrossRefGoogle Scholar
  34. 34.
    Grasso M, Conlin M, Bagley D: Retrograde ureteropyeloscopic treatment of 2 cm or greater upper urinary tract and minor Staghorn calculi. J Urol 1998, 160:346–351.PubMedCrossRefGoogle Scholar
  35. 35.
    Fraundorfer MR, Gilling PJ, Kennett KM, et al.: Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study. Urology 2001, 57:454–458.PubMedCrossRefGoogle Scholar
  36. 36.
    Kim SC, Kuo RL, Paterson RF, et al.: Combined use of holmium laser enucleation of prostate (HoLEP) with endourologic upper tract procedures. J Endourol 2003, 17:A193-A194.CrossRefGoogle Scholar
  37. 37.
    Kuo RL, Paterson RF, Siqueira TM Jr, et al.: Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology 2003, 62:59–63.PubMedCrossRefGoogle Scholar
  38. 38.
    Borboroglu PG, Kane CJ, Ward JF, et al.: Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999, 162:1307–1310.PubMedCrossRefGoogle Scholar
  39. 39.
    Vavassori I, Hurle R, Vismara A, et al.: Holmium laser enucleation of the prostate combined with mechanical morcellation: 2 years of experience with 196 patients. J Endourol 2004, 18:109–112.PubMedCrossRefGoogle Scholar
  40. 40.
    McConnell JD, Barry MJ, Brushewitz RC, et al.: Clinical practice guideline: benign prostatic hyperplasia. Diagnosis and treatment (publication no. 94-0582). Agency for Health Care Policy and Research, US Public Health Service; 1994.Google Scholar
  41. 41.
    Lepor H, Wang B, Shapiro E: Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology 1994, 44:199–205.PubMedCrossRefGoogle Scholar
  42. 42.
    Lloyd SN, Collins GN, McKelvie GB, et al.: Predicted and actual change in serum PSA following prostatectomy for BPH. Urology 1994, 43:472–479.PubMedCrossRefGoogle Scholar
  43. 43.
    Cadeddu JA, Pearson JD, Lee BR, et al.: Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia. Urology 1995, 45:795–800.PubMedCrossRefGoogle Scholar
  44. 44.
    Stamey TA, Dietrick DD, Issa MM: Large, organ-confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. J Urol 1993, 149:510–515.PubMedGoogle Scholar
  45. 45.
    Marks LS, Dorey FJ, Rhodes T, et al.: Serum prostate-specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia. J Urol 1996, 156:1035–1039.PubMedCrossRefGoogle Scholar
  46. 46.
    Stamey TA, Yang N, Hay AR, et al.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987, 317:909–916.PubMedCrossRefGoogle Scholar
  47. 47.
    Ozden C, Inal G, Adsan O, et al.: Detection of prostate cancer and changes in prostate-specific antigen (PSA) 6 months after surgery for benign prostatic hyperplasia in patients with elevated PSA. Urol Int 2003, 71:150–153.PubMedCrossRefGoogle Scholar
  48. 48.
    Aus G, Bergdahl S, Frosing R, et al.: Reference range of prostate-specific antigen after transurethral resection of the prostate. Urology 1996, 47:529–531.PubMedCrossRefGoogle Scholar
  49. 49.
    Hai MA, Malek RS: Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003, 17:93–96.PubMedCrossRefGoogle Scholar
  50. 50.
    Seki N, Mochida O, Kinukawa N, et al.: Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 2003, 170:1847–1850.PubMedCrossRefGoogle Scholar
  51. 51.
    Malek RS, Kuntzman RS, Barrett DM: High power potassiumtitanyl-phosphate laser vaporization prostatectomy. J Urol 2000, 163:1730–1733.PubMedCrossRefGoogle Scholar
  52. 52.
    Kabalin JN: Editorial comment: techniques in endourology holmium:YAG laser resection of the prostate. J Endourol 1999, 13:218–219.Google Scholar
  53. 53.
    Lingeman JE: Editorial comment: holmium laser enucleation vs transurethral resection in large prostates. J Urol 2003, 170:1274.CrossRefGoogle Scholar
  54. 54.
    El-Hakim A, Elhilali MM: Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 2002, 90:863–869.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Samuel C. Kim
    • 1
  • James E. Lingeman
    • 1
  1. 1.Indiana University School of Medicine, and Indiana Kidney Stone InstituteMethodist Hospital Institute for Kidney Stone DiseaseIndianapolisUSA

Personalised recommendations